4.1.5. follow-up. follow-up women oab guided type treatment instituted local service capacity. standardisation follow-up pathways therefore difficult. here, provide recommendations based best practice standards clinical trials. 4.1.5.1. recommendations follow-up patients overactive bladder recommendationsstrength ratingoffer early follow-up women commenced anticholinergic beta-3 agonist therapy.strongoffer repeat injections onabotulinumtoxina, required, women effective (refer manufacturerâ€™s guidance regarding minimum timeframe repeat injections).strongoffer life-long surveillance women sacral nerve stimulation implant monitor lead displacement, malfunction, battery wear.strongoffer cystoscopic surveillance women augmentation cystoplasty due small risk malignancy.weak